Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Doximity (DOCS) News Today

Doximity logo
$33.46 -0.23 (-0.67%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$32.62 -0.84 (-2.51%)
As of 10/23/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Doximity Down Today?

Doximity, Inc. (NYSE: DOCS) is facing negative investor sentiment as a wave of securities-class-action notices and a reiterated analyst sell rating increase concerns about the company’s disclosures, advertising strategy, and future growth. The stock remains well above its 12-month low, but its valuation—approximately 39 times earnings—leaves it vulnerable to further pressure if growth slows or legal risks escalate.

  • Neutral Sentiment: Analysts remain divided on Doximity’s artificial-intelligence opportunity and profit margins. One report said the company received a fair-value increase, suggesting some support from potential AI-driven growth, while Wells Fargo maintained its Sell rating, highlighting continuing disagreement over the outlook. Doximity Stock Gets Fair Value Bump Wells Fargo Keeps Sell Rating
  • Negative Sentiment: Multiple law firms reiterated that a securities class action has been filed against Doximity on behalf of investors who purchased shares from August 8, 2024, through May 13, 2026. The notices allege that the company made misleading statements about its advertising formats and e-newsletter products, including assurances that users would not encounter banner ads. These are allegations, not proven findings, but the litigation creates potential legal costs, reputational risk, and uncertainty around the company’s business disclosures. Doximity Shareholder Alert Class Action Filed Alleging Investor Harm
  • Negative Sentiment: Investors affected by the alleged losses have until November 16, 2026 to seek appointment as lead plaintiff. The large number of nearly identical law-firm announcements keeps the lawsuit in the market’s focus and may weigh on DOCS shares. Doximity Investor Alert and Deadline
Posted 1+ days agoAI Generated. May Contain Errors.

Doximity Latest News

Wells Fargo Keeps Their Sell Rating on Doximity (DOCS)
Doximity (NYSE:DOCS) Shares Up 8% - Should You Buy?
Doximity (NYSE:DOCS) CAO Sells $80,166.84 in Stock
Why Doximity (DOCS) Dipped More Than Broader Market Today
Doximity Extends Partnership With US News & World Report

Doximity Media Mentions By Week

Doximity Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DOCS
News Sentiment
▼
0.20

0.46
▲
Average
Healthcare
News Sentiment

Doximity News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DOCS Articles
This Week
▼
30

8
▲
DOCS Articles
Average Week

Doximity Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
1
Page Views
2,994
-8%
Get Doximity News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Doximity dated 10/23/2026.
From Our Partners